Barbara J. Gitlitz

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip, Nasser K. Altorki, Caicun Zhou et al. · The Lancet · 2021 · 1.5K citations

Medicine, Oncology, Pharmacology +13

Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

Amnon Zisman, Allan J. Pantuck, Fredrick Dorey et al. · Journal of Clinical Oncology · 2001 · 733 citations

Medicine, Oncology, Surgery +17

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui et al. · Journal of Clinical Oncology · 2018 · 466 citations · Full text

Medicine, Oncology, Pharmacology +17

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer

Lecia V. Sequist, Benjamin Besse, Thomas J. Lynch et al. · Journal of Clinical Oncology · 2010 · 426 citations · Full text

Medicine, Oncology, Pharmacology +16

Renal Cell Carcinoma With Retroperitoneal Lymph Nodes: Role of Lymph Node Dissection

Allan J. Pantuck, Amnon Zisman, Fredrick Dorey et al. · The Journal of Urology · 2003 · 304 citations

Medicine, Oncology, Surgery +16